Should You Buy APHA?

 

Aphria Inc. (“Aphria,” “we, ” or the “Company”) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today reported its financial results for the third quarter and nine months ended February 28, 2021. All amounts are expressed in Canadian dollars, unless otherwise noted and except for per gram, kilogram, kilogram equivalents, and per share amounts.

Irwin D. Simon, Chairman and Chief Executive Officer, commented, “Our global team executed well in the very fluid, ongoing COVID-19 operating environment. We proactively managed our expenses and maintained our positive adjusted EBITDA for the third quarter of fiscal 2021. The duration and impact of lockdowns across many of the regions we operate in, particularly in Canada, were greater than we initially anticipated for the cannabis industry and our business; however, we believe Aphria remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves. In the U.S., we had a solid first full quarter of contribution from SweetWater even with lower on-premise sales compared to the prior year quarter as many foodservice industry establishments were still operating with limited capacity. Going forward, we are excited about the strategic opportunities for incremental growth as we look to parlay our branded consumer products into additional complementary product offerings in Canada, the U.S. and internationally.”

Mr. Simon continued, “We remain excited with the opportunities created for both Aphria shareholders and Tilray stockholders in completing our proposed business combination with Tilray, and believe that together, we will create one of the strongest global cannabis and consumer packaged goods companies in the world. We expect to have a tremendous runway for long-term sustainable growth as we build upon our existing foundation in Canada and internationally by increasing the scale of our global operations. We expect Aphria and Tilray’s complementary cultures of innovation, brand development and cultivation to further set us apart from others in the industry along with the strength of our balance sheet and cash availability as we enhance value for all stakeholders.”

Key Operating Highlights — Third Quarter Fiscal 2021
— Reached a definitive agreement to combine with Tilray, Inc. (“Tilray”) to
create the world’s largest global cannabis company based on pro forma
revenue1,

— Closed a USD $120 million financing with BMO, providing a USD $20 million
revolving facility and USD $100 million term debt facility;

— Maintained its #1 licensed producer status in Ontario and Alberta in
terms of sales to the provincial boards, based on Headset data for the
period December 2020 to February 2021, the same as its prior fiscal
quarter;

— Improved its market share in Quebec, rising to #2 licensed producer in
terms of sales to the provincial board, based on internal analyses;

— Recorded eighth consecutive quarter of positive adjusted EBITDA2 and
positive adjusted EBITDA from cannabis business2;

— Adjusted EBITDA from cannabis business2 of $7.9 million in the third
quarter compared to $12.9 million in the prior quarter;

— Adjusted EBITDA2 increased to $12.7 million in the third quarter compared
to $12.6 million in the prior quarter;

— Free cash flow2 improved $12.4 million during the third quarter
predominantly as a result of increased cash provided by operating
activities, as the Company better managed its working capital;

— Third quarter revenues were impacted by lockdowns in the major Canadian
provinces, particularly Ontario, which was in a lockdown for nearly the
entire quarter, and in Germany;

— Gross revenue for adult-use cannabis of $59.6 million in the third
quarter, an increase of 33.4% from the prior year quarter, and a decrease
of 17.3% from the prior quarter;

— Net cannabis revenue of $51.7 million in the third quarter, a decrease of
7.8% from the prior year quarter, and a decrease 23.8% from the prior
quarter;

— Net revenue of $153.6 million in the third quarter, an increase of 6.4%
from the prior year quarter, and a decrease of 4.3% from the prior
quarter;

— Ended the third quarter with a strong balance sheet and liquidity,
including $267.1 million of cash and cash equivalents to fund planned
Canadian and international growth;

— Broken Coast expanded its premium cannabis offering with introduction of
newly developed strain “Pipe Dream;”

— Launched SweetWater Brewing Company, LLC (“SweetWater”) beverages
statewide in Colorado, the first U.S. state to legalize adult-use
cannabis; and,

— Introduced the Solei brand topical, a high potency topical available in
the Canadian market.
Subsequent Events
— Launched www.aphriatilraytogether.com, for shareholders of Aphria and
Stockholders of Tilray to find up-to-date information about the proposed
Aphria-Tilray business combination;

— Scheduled special meeting of Aphria shareholders on April 14, 2021 to
approve the proposed Aphria-Tilray business combination; and,

— Received vote FOR recommendations from ISS and Glass Lewis for the
Aphria-Tilray business combination. ISS and Glass Lewis are leading
independent proxy advisory firms that provide voting recommendations to
institutional shareholders.
Key Financial Highlights (In thousands of Canadian dollars)

Three months ended Three months ended
February 28, 2021 February 29, 2020
Net revenue $153,638 $144,424
Gross profit $31,689 $59,575
Adjusted cannabis gross profit (1) $20,272 $23,744
Adjusted cannabis gross margin (1) 39.2% 42.7%
Adjusted beverage alcohol gross profit
(1) $7,092 N/A
Adjusted beverage alcohol gross margin
(1) 47.9% N/A
Adjusted distribution gross profit (1) $11,437 $11,397
Adjusted distribution gross margin (1) 13.1% 12.9%
Net income (loss) ($360,996) $5,697
Adjusted net income (loss) (1) ($47,924) ($9,844)
Adjusted EBITDA (1) $12,651 $5,736

Q3-2021 Q2-2021
Distribution revenue $87,095 $91,740
Net cannabis revenue $51,735 $67,911
Net beverage alcohol revenue $14,808 $881
Net revenue $153,638 $160,532
Kilograms (or kilogram equivalents)
sold (1) 18,695 26,730
Cash cost to produce dried cannabis /
gram(1) $0.90 $0.79
“All-in” cost of goods sold / gram(1) $1.54 $1.30
Adjusted EBITDA from cannabis business
(1) $7,858 $12,887
Adjusted EBITDA from businesses under
development (1) ($1,495) ($3,199)
Adjusted EBITDA from beverage alcohol
business (1) $5,002 $299
Adjusted EBITDA from distribution
business (1) $1,286 $2,585
Cash and cash equivalents & marketable
securities $267,134 $187,997
Working capital $513,713 $399,161
Capital and intangible asset
expenditures – wholly-owned
subsidiaries (1) $4,984 $16,935
Capital and intangible asset
expenditures -majority-owned
subsidiaries(1) $61 $2,791

Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4% from $144.4 million in the same period last year. Third quarter fiscal year 2021 net revenue decreased 4.3% when compared to the prior quarter net revenue of $160.5 million, due to a decrease in net cannabis and distribution revenue, partially offset by an increase in net beverage alcohol revenue from the acquisition of SweetWater.

As a result of the ongoing effects of COVID-19, including provincial lockdowns and provincial boards taking measures to lower their inventory levels which had previously included forecasted cannabis market growth, the Company experienced what it believes is a transitory reduction in demand during the quarter. These provincial government measures resulted in decreased orders from provincial boards and product returns of approximately $5.0 million. The Company mitigated a portion of the product return by finding alternative distribution channels for some of the products, but experienced a reduction in net cannabis revenue as a result of $4.1 million.

The average retail selling price of medical cannabis, before excise tax, decreased to $6.69 per gram in the quarter, compared to $6.96 per gram in the prior quarter. The decline was a result of specific pricing programs offered to assist patients in need who have been negatively impacted by the COVID-19 pandemic, along with other promotional programs.

The average selling price of adult-use cannabis, before excise tax, decreased to $3.82 per gram in the quarter, compared to $4.29 per gram in the prior quarter, primarily due to consumer trends towards the purchase of large-format and price compression in the market.

2021-04-12 11:00:00 GMT (PR) Aphria Inc. Announces Third Quarter Fiscal -2-

Adjusted cannabis gross profit for the third quarter was $20.3 million, with an adjusted cannabis gross margin of 39.2%, compared to $31.2 million and 45.9%, respectively in the prior quarter. The decrease in adjusted cannabis gross profit and adjusted cannabis gross margin(1) was primarily due to lower yields that are typically experienced in the Company’s third quarter, due to less sunlight in December through February, and the impacts of the product returns described above. The remaining difference was due to the overall decrease in average selling price based on sales mix.

Adjusted distribution gross profit for the third quarter was $11.4 million, with an adjusted distribution gross margin of 13.1%, compared to $12.1 million and 13.1% in the prior quarter. The decrease in adjusted distribution gross profit(1) was a result of a decrease in distribution revenue at Aphria’s CC Pharma subsidiary in Germany driven by COVID-19 restrictions, which negatively impacted pharmacy revenue and the importation of inventory from other countries.

During the quarter, the Company’s adjusted gross margin on beverage alcohol decreased from 60.5% to 47.9%. The prior quarter’s gross margin included only 5 days of sales with a sales mix that more heavily skewed towards on-premises consumption in the prior quarter.

Operating expenses in the quarter increased to $100.0 million from $82.7 million in the prior quarter and increased from $50.9 million from the third quarter of the prior year. The increase from the prior quarter was primarily driven by the impacts of the growth in the Company’s share price in the quarter on non-cash share-based compensation expense and the addition of a full quarter of operating expenses from SweetWater, including the amortization charges on its assets. The remaining increase is from transaction costs associated with the acquisition of SweetWater, the proposed business combination with Tilray, other potential acquisitions and one-time litigation costs. During the quarter, management identified that COVID-19 and the provincial lockdowns were going to be more impactful than initially expected. In response, management implemented several cost savings initiatives in the quarter, protecting the Company’s profitability and adjusted EBITDA.

Net loss for the third quarter of fiscal year 2021 was $361.0 million, or a loss of $1.14 per share, compared to a net loss $120.6 million, or a loss of $0.42 per share in the prior quarter, and net income of $5.7 million, or earnings $0.02 per share in the third quarter last year. On an adjusted basis excluding the impacts of the items noted in the reconciliation table below, the Company recorded a net loss for the third quarter of fiscal year 2021 of $47.9 million, or a loss of $0.15 per share.

For the three months ended For the nine months ended
February 28, February 28,
2021 2020 2021 2020
Net (loss)
income $ (360,996) $ 5,697 $ (486,689) $ 14,209
Unrealized
loss (gain)
on
convertible
debentures 264,788 (23,145) 352,013 (86,430)
Share-based
compensation 36,271 5,126 54,127 17,645
Transaction
costs 12,013 2,478 37,637 3,904
Adjusted net
income
(loss) $ (47,924) $ (9,844) $ (42,912) $ (50,672)

Adjusted
income (loss)
per share –
basic(2) $ (0.15) $ (0.04) $ (0.14) $ (0.20)

Adjusted EBITDA increased to $12.7 million for the third quarter compared to $12.6 million the prior quarter. Adjusted EBITDA from cannabis business for the third quarter was $7.9 million compared to $12.9 million in the prior quarter. Adjusted EBITDA loss from businesses under development for the third quarter was $1.5 million compared to adjusted EBITDA loss of $3.2 million in the prior quarter. Adjusted EBITDA from the beverage alcohol business was $5.0 million for the third quarter compared to $0.3 million for the prior quarter with the third quarter of fiscal 2021 representing the first full quarter contribution of SweetWater’s operations in the Company’s results. Adjusted EBITDA from distribution business for the third quarter was $1.3 million, compared to $2.6 million in the prior quarter.

The Company continued to improve its free cash flow in the quarter, as the Company moved closer to its target of generating positive free cash flow.

Q3 – 2021 Q2 – 2021

Cash provided by (used in) operating
activities: $ 1,150 $ 3,404
Investment in capital and intangible assets (5,045) (19,726)
Free cash flow $ (3,895) $ (16,322)

 

About Aphria Inc.

Aphria Inc. is a leading global cannabis-lifestyle consumer packaged goods company with operations in Canada, the United States, Europe and Latin America, that is changing people’s lives for the better — one person at a time — by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body and soul and invoke a sense of wellbeing. Aphria’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. Headquartered in Leamington, Ontario, Aphria cultivates, processes, markets and sells medical and adult-use cannabis, cannabis-derived extracts and derivative cannabis products in Canada under the provisions of the Cannabis Act and globally pursuant to applicable international regulations. Aphria also manufactures, markets and sells alcoholic beverages in the United States. For more information, visit: aphriainc.com.


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer


>